TA172 Head and neck cancer (squamous cell carcinoma) - cetuximab: understanding NICE guidance (MS Word version)
|
TA172 Head and neck cancer (squamous cell carcinoma) - cetuximab: understanding NICE guidance (MS Word version)
24 June 2009 (508.5 Kb 2 mins 28 sec) |
